Tucson Citizen – Blood Thinner Safety Effort Touted
A Tucson-based research institute says it is improving the safety of a widely used blood thinning drug.
Related Posts
-
C-Path Receives COA Qualification from FDA for the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ) -
Critical Path Institute Receives Regulatory Support for Liver Injury Biomarker -
miR-122 An Exploratory Biomarker of Liver Injury: An Industry Perspective on the State of the Science and Experiences Pre-Clinically and Clinically -
Two Arizona leaders in scientific collaboration partner to advance global TB research -
For Two Arizona-Based Nonprofits, Past Meets Present on World TB Day